Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K M Debatin

Showing results (21-30 of 239) with videos related to

Pageof 24
Sort By:
Leukemia|May 1, 1995
Resistance to APO-1 (CD95) induced apoptosis in T-ALL is determined by a BCL-2 independent anti-apoptotic programK M Debatin, P H Krammer
Current Biology : CB|July 1, 1992
When apoptosis failsP H Krammer, K M Debatin
BMC Molecular Biology|September 5, 2001
HIPK2 overexpression leads to stabilization of p53 protein and increased p53 transcriptional activity by decreasing Mdm2 protein levelsY Wang, K M Debatin, H Hug
Advances in Experimental Medicine and Biology|January 1, 1982
The role of the cell membrane in the killing mechanism of polymorphonuclear leucocytes (PMN)J Menzel, K M Debatin, H Bannert
Journal of Molecular Medicine (Berlin, Germany)|March 28, 2001
Suicide gene therapy for pediatric tumorsC Beltinger, W Uckert, K M Debatin
Blood|October 3, 1999
Sensitivity of CD4+ peripheral blood T cells toward spontaneous and CD95 (APO-1/Fas)-induced apoptosis in pediatric human immunodeficiency virus infectionT Böhler, K M Debatin, R Linde
Leukemia|November 22, 1997
Deficient activation of the CD95 (APO-1/Fas) system in drug-resistant cellsC Friesen, S Fulda, K M Debatin
Cell Death and Differentiation|April 24, 2004
A critical role of glutathione in determining apoptosis sensitivity and resistance in leukemia cellsC Friesen, Y Kiess, K-M Debatin
Cell Death and Differentiation|June 25, 1999
Induction of CD95 ligand and apoptosis by doxorubicin is modulated by the redox state in chemosensitive- and drug-resistant tumor cellsC Friesen, S Fulda, K M Debatin
Leukemia|November 11, 1999
Cytotoxic drugs and the CD95 pathwayC Friesen, S Fulda, K M Debatin
Pageof 24

Showing results (21-30 of 239) with videos related to

Sort By:
Pageof 24
Leukemia|May 1, 1995
Resistance to APO-1 (CD95) induced apoptosis in T-ALL is determined by a BCL-2 independent anti-apoptotic programK M Debatin, P H Krammer
Current Biology : CB|July 1, 1992
When apoptosis failsP H Krammer, K M Debatin
BMC Molecular Biology|September 5, 2001
HIPK2 overexpression leads to stabilization of p53 protein and increased p53 transcriptional activity by decreasing Mdm2 protein levelsY Wang, K M Debatin, H Hug
Advances in Experimental Medicine and Biology|January 1, 1982
The role of the cell membrane in the killing mechanism of polymorphonuclear leucocytes (PMN)J Menzel, K M Debatin, H Bannert
Journal of Molecular Medicine (Berlin, Germany)|March 28, 2001
Suicide gene therapy for pediatric tumorsC Beltinger, W Uckert, K M Debatin
Blood|October 3, 1999
Sensitivity of CD4+ peripheral blood T cells toward spontaneous and CD95 (APO-1/Fas)-induced apoptosis in pediatric human immunodeficiency virus infectionT Böhler, K M Debatin, R Linde
Leukemia|November 22, 1997
Deficient activation of the CD95 (APO-1/Fas) system in drug-resistant cellsC Friesen, S Fulda, K M Debatin
Cell Death and Differentiation|April 24, 2004
A critical role of glutathione in determining apoptosis sensitivity and resistance in leukemia cellsC Friesen, Y Kiess, K-M Debatin
Cell Death and Differentiation|June 25, 1999
Induction of CD95 ligand and apoptosis by doxorubicin is modulated by the redox state in chemosensitive- and drug-resistant tumor cellsC Friesen, S Fulda, K M Debatin
Leukemia|November 11, 1999
Cytotoxic drugs and the CD95 pathwayC Friesen, S Fulda, K M Debatin
Pageof 24